<DOC>
	<DOCNO>NCT00900991</DOCNO>
	<brief_summary>A single center , stratify , randomize double-blind phase II clinical trial conduct child evaluate safety immunogenicity split-virion pandemic influenza A vaccine ( H5N1 ) .</brief_summary>
	<brief_title>Safety Immunogenicity Split-Virion Pandemic Influenza A ( H5N1 ) Vaccine Children</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy child age 311 year old Be able show legal identity card sake recruitment Volunteers parent able understand sign inform consent Do participate clinical trial Any history allergic reaction Autoimmune disease immunodeficiency Asthma unstable require emergent care , hospitalization intubation past two year require use oral intravenous corticosteroid Diabetes mellitus ( type I II ) , exception gestational diabetes History thyroidectomy thyroid disease require medication within past 12 month Serious angioedema episode within previous 3 year require medication previous two year Hypertension well control medication blood pressure 145/95 mmHg enrollment Bleeding disorder diagnose doctor ( e.g. , factor deficiency , coagulopathy , platelet disorder require special precaution ) significant bruise bleed difficulty IM injection blood draw Active malignancy treat malignancy reasonable assurance sustain cure malignancy likely recur period study Seizure disorder : 1 . Febrile seizures age two year old 2 . Seizures secondary alcohol withdrawal 3 year ago , 3 . A singular seizure require treatment within last 3 year Asplenia , functional asplenia condition result absence removal spleen GuillainBarre Syndrome Any history immunosuppressive medication cytotoxic medication inhale corticosteroid within past six month ( exception corticosteroid nasal spray allergic rhinitis topical corticosteroid acute uncomplicated dermatitis ) History blood product administration within 3 month dose Administration investigational research agent within 30 day dose Administration live attenuate vaccine within 30 day dose Administration subunit inactivate vaccine , e.g . pneumococcal vaccine , allergy treatment antigen injection , within 14 day dose Be receive antiTB prophylaxis therapy currently Axillary temperature &gt; 37.0 centigrade time dose Psychiatric condition precludes compliance protocol : 1 . Past present psychosis 2 . Past present bipolar disorder require therapy well control medication past two year 3 . Disorder require lithium 4 . Suicidal ideation occur within five year prior enrollment Any medical , psychiatric , social condition , occupational reason responsibility , judgment investigator , contraindication protocol participation impair volunteer 's ability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Pandemic Influenza A Vaccine</keyword>
	<keyword>Immunogenictiy</keyword>
	<keyword>Safety</keyword>
</DOC>